The role of corepressors in transcriptional regulation by nuclear hormone receptors

Annual Review of Physiology

Volumn 66, Issue , 2004, Pages 315-360

  Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Histone deacetylases; N CoR; Nuclear receptors; SMRT; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; HISTONE DEACETYLASE; HORMONE RECEPTOR; NUCLEAR RECEPTOR COREPRESSOR; TRANSCRIPTION FACTOR; CELL RECEPTOR; DNA BINDING PROTEIN; NUCLEAR PROTEIN; NUCLEAR RECEPTOR CO REPRESSOR 1; NUCLEAR RECEPTOR CO REPRESSOR 2; NUCLEAR RECEPTOR CO-REPRESSOR 1; NUCLEAR RECEPTOR CO-REPRESSOR 2; REPRESSOR PROTEIN;

CHROMATIN; ENDOCRINE DISEASE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; GENETIC TRANSCRIPTION; HISTONE CODE; PHYSIOLOGY;

ANIMALS; DNA-BINDING PROTEINS; HISTONE CODE; HISTONE DEACETYLASES; HUMANS; NUCLEAR PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 2342573009     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.66.032802.155556     Document Type: Review

References (353)

1. Laudet V. 1997. Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J. Mol. Endocrinol. 19:207-26
2. Whitfield GK, Jurutka PW, Haussler CA, Haussler MR. 1999. Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J. Cell Biochem. Suppl. 32-33:10-22
3. Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, et al. 1998. Molecular and structural biology of thyroid hormone receptors. Clin. Exp. Pharmacol. Physiol. Suppl. 25:S2-11
4. Beato M, Klug J. 2000. Steroid hormone receptors: an update. Hum. Reproduction Update 6:25-36
5. Hager GL. 2001. Understanding nuclear receptor function: from DNA to chromatin to the interphase nucleus. Prog. Nucleic Acid Res. Mol. Biol. 66:279-305
6. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-39
7. Zhang J, Lazar MA. 2000. The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62:439-66
8. Hihi AK, Michalik L, Wahli W. 2002. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol. Life Sci. 59:790-98
9. Waxman DJ. 1999. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369:11-23
10. Kliewer SA, Lehmann JM, Milburn MV, WillsonTM. 1999.The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways. Recent Prog. Horm. Res. 54:345-67; discussion 67-68
11. Repa JJ, Mangelsdorf DJ. 1999. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotech. 10:557-63
12. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-50
13. Pereira FA, Tsai MJ, Tsai SY. 2000. COUP-TF orphan nuclear receptors in development and differentiation. Cell Mol. Life Sci. 57:1388-98
14. Khorasanizadeh S, Rastinejad F. 2001. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26:384-90
15. Kumar R, Thompson EB. 1999. The structure of the nuclear hormone receptors. Steroids 64:310-19
16. Ribeiro RC, Apriletti JW, Wagner RL, West BL, Feng W, et al. 1998. Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies. Recent Prog. Horm. Res. 53:351-92; discussion 92-94
17. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH. 1992. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol. Endocrinol. 6:429-42
18. Forman BM, Evans RM. 1995. Nuclear hormone receptors activate direct, inverted, and everted repeats. Ann. NY Acad. Sci. 761:29-37
19. Glass CK. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391-407
20. Glass CK. 1996. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J. Endocrinol. 150:349-57
21. 3 signalling. Nature 355:446-49
22. Kurokawa R, Yu VC, Näär A, Kyakumoto S, Han Z, et al. 1993. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:423-35
23. Lazar MA, Berrodin TJ, Harding HP. 1991. Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor. Mol. Cell Biol. 11:5005-15
24. Moore DD, Brent GA. 1991. Thyroid hormone - half-sites and insights. New Biol. 3:835-44
25. Näär AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, et al. 1991. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267-79
26. Perlmann T, Rangarajan PN, Umesono K, Evans RM. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7:1411-22
27. 3 receptors. Cell 65:1255-66
28. Göttlicher M, Heck S, Herrlich P. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:480-89
29. Miner JN, Yamamoto KR. 1991. Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 16:423-26
30. Saatcioglu F, Claret FX, Karin M. 1994. Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol. 5:347-59
31. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. 2000. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5:289-98
32. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, et al. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-89
33. Tanenbaum DM, Wang Y, Williams SP, Sigler PB. 1998. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA 95:5998-6003
34. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-97
35. Wagner RL, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, et al. 2001. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 15:398-410
36. Williams SP, Sigler PB. 1998. Atomic structure of progesterone complexed with its receptor. Nature 393:392-96
37. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-58
38. Paige LA, Christensen DJ, Grøn H, Norris JD, Gottlin EB, et al. 1999. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc. Natl. Acad. Sci. USA 96:3999-4004
39. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, et al. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-37
40. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, et al. 2002. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415:813-17
41. Aranda A, Pascual A. 2001. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:1269-304
42. Chen JD, Li H. 1998. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit. Rev. Eukaryot. Gene Expr. 8:169-90
43. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. 1996. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1167-77
44. Ito M, Roeder RG. 2001. The TRAP/SMCC/mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12:127-34
45. Jenster G. 1998. Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol. Cell Endocrinol. 143:1-7
46. Koenig RJ. 1998. Thyroid hormone receptor coactivators and corepressors. Thyroid 8:703-13
47. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK. 2001. Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol. Life Sci. 58:289-97
48. Leo C, Chen JD. 2000. The SRC family of nuclear receptor coactivators. Gene 245:1-11
49. McKenna NJ, O'Malley BW. 2002. Minireview: nuclear receptor coactivators - an update. Endocrinology 143:2461-65
50. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. 1999. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69:3-12
51. Ordentlich P, Downes M, Evans RM. 2001. Corepressors and nuclear hormone receptor function. Curr. Top. Microbiol. Immunol. 254:101-16
52. Rachez C, Freedman LP. 2001. Mediator complexes and transcription. Curr. Opin. Cell Biol. 13:274-80
53. Xu L, Glass CK, Rosenfeld MG. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:140-47
54. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, et al. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:3343-56
55. Mak HY, Hoare S, Henttu PM, Parker MG. 1999. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell Biol. 19:3895-903
56. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, et al. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137-43
57. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM. 1999. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98:675-86
58. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, et al. 2000. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol. Cell Biol. 20:7541-49
59. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-52
60. Sharma D, Fondell JD. 2000. Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. Mol. Endocrinol. 14:2001-9
61. Sharma D, Fondell JD. 2002. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. USA 99:7934-39
62. Struhl K. 2001. Gene regulation. A paradigm for precision. Science 293:1054-55
63. Yang W, Rachez C, Freedman LP. 2000. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Mol. Cell Biol. 20:8008-17
64. Chen JD, Evans RM. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-57
65. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
66. Sande S, Privalsky ML. 1996. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10:813-25
67. Seol W, Mahon MJ, Lee YK, Moore DD. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10:1646-55
68. Zamir I, Harding HP, Atkins GB, Horlein A, Glass CK, et al. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell Biol. 16:458-65
69. Tsai CC, Kao HY, Yao TP, McKeown M, Evans RM. 1999. SMRTER, a Drosophila nuclear receptor coregulator, reveals that EcR-mediated repression is critical for development. Mol. Cell 4:175-86
70. Jones PL, Shi YB. 2003. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr. Top. Microbiol. Immunol. 274:237-68
71. Nawaz Z, Tsai MJ, O'Malley BW. 1995. Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta. Proc. Natl. Acad. Sci. USA 92:11691-95
72. Tong GX, Jeyakumar M, Tanen MR, Bagchi MK. 1996. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol. Cell Biol. 16:1909-20
73. Torchia J, Glass C, Rosenfeld MG. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373-83
74. Muscat GE, Burke LJ, Downes M. 1998. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res. 26:2899-907
75. Wong CW, Privalsky ML. 1998. Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol. Cell Biol. 18:5500-10
76. Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-77
77. Chan HM, La Thangue NB. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-73
78. McManus KJ, Hendzel MJ. 2001. CBP, a transcriptional coactivator and acetyltransferase. Biochem. Cell Biol. 79:253-66
79. Blobel GA. 2002. CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J. Leukoc. Biol. 71:545-56
80. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110:55-67
81. Espinosa L, Ingles-Esteve J, Robert-Moreno A, Bigas A. 2003. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. Mol. Biol. Cell 14:491-502
82. Espinosa L, Santos S, Ingles-Esteve J, Munoz-Canoves P, Bigas A. 2002. p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. J. Cell Sci. 115:295-303
83. 2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-kappa B transactivation via phosphorylation of the p65 subunit. J. Biol. Chem. 276:20005-10
84. Lee SK, Kim JH, Lee YC, Cheong J, Lee JW. 2000. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J. Biol. Chem. 275:12470-74
85. Luo K, Stroschein SL, Wang W, Chen D, Martens E, et al. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 13:2196-206
86. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, et al. 1998. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 12:2269-77
87. Oswald F, Kostezka U, Astrahantseff K, Bourteele S, Dillinger K, et al. 2002. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J. 21:5417-26
88. Zhou S, Hayward SD. 2001. Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex. Mol. Cell Biol. 21:6222-32
89. Li X, McDonnell DP. 2002. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT. Mol. Cell Biol. 22:3663-73
90. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, et al. 1998. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat. Genet. 18:126-35
91. Hong SH, David G, Wong CW, Dejean A, Privalsky ML. 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:9028-33
92. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811-14
93. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, et al. 2002. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell Biol. 22:1804-18
94. Wong CW, Privalsky ML. 1998. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 273:27695-702
95. Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, et al. 1997. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA 94:10762-67
96. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, et al. 1998. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26:4645-51
97. Asahara H, Dutta S, Kao HY, Evans RM, Montminy M. 1999. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol. Cell Biol. 19:8219-25
98. Laherty CD, Billin AN, Lavinsky RM, Yochum GS, Bush AC, et al. 1998. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol. Cell 2:33-42
99. Saleh M, Rambaldi I, Yang XJ, Featherstone MS. 2000. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol. Cell Biol. 20:8623-33
100. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, et al. 2000. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-31
101. Xu L, Lavinsky RM, Dasen JS, Flynn SE, McInerney EM, et al. 1998. Signalspecific co-activator domain requirements for Pit-1 activation. Nature 395:301-6
102. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, et al. 2001. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell Biol. 21:6470-83
103. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA. 1998. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell Biol. 18:7185-91
104. Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, et al. 2001. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Cancer Chemother. Pharmacol. 48(Suppl. 1):S31-34
105. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, et al. 1998. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell Biol. 18:7176-84
106. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. 1998. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA 95:10860-65
107. Nguyen TA, Hoivik D, Lee JE, Safe S. 1999. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch. Biochem. Biophys. 367:250-57
108. Bailey P, Downes M, Lau P, Harris J, Chen SL, et al. 1999. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13:1155-68
109. Sande S, Sharif M, Chen H, Privalsky M. 1993. v-erbA acts on retinoic acid receptors in immature avian erythroid cells. J. Virol. 67:1067-74
110. Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, Evans RM. 1999. Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc. Natl. Acad. Sci. USA 96:2639-44
111. Park EJ, Schroen DJ, Yang M, Li H, Li L, Chen JD. 1999. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc. Natl. Acad. Sci. USA 96:3519-24
112. Chen JD, Umesono K, Evans RM. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-71
113. Downes M, Burke LJ, Bailey PJ, Muscat GE. 1996. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: Physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res. 24:4379-86
114. Harding HP, Atkins GB, Jaffe AB, Seo WJ, Lazar MA. 1997. Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development. Mol. Endocrinol. 11:1737-46
115. Li H, Leo C, Schroen DJ, Chen JD. 1997. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11:2025-37
116. Wong CW, Privalsky ML. 1998. Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol. Cell Biol. 18:5724-33
117. Zamir I, Zhang J, Lazar MA. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11:835-46
118. Zamir I, Dawson J, Lavinsky RM, Glass CK, Rosenfeld MG, Lazar MA. 1997. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc. Natl. Acad. Sci. USA 94:14400-5
119. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-41
120. Privalsky ML. 2001. Regulation of SMRT and N-CoR corepressor function. Curr. Top. Microbiol. Immunol. 254:117-36
121. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN. 2001. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol. Endocrinol. 15:1049-61
122. Makowski A, Brzostek S, Cohen RN, Hollenberg AN. 2003. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol. Endocrinol. 17:273-86
123. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, et al. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:1976-85
124. Cohen RN, Putney A, Wondisford FE, Hollenberg AN. 2000. The nuclear corepressors recognize distinct nuclear receptor complexes. Mol. Endocrinol. 14:900-14
125. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, et al. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95:2920-25
126. Cohen RN, Wondisford FE, Hollenberg AN. 1998. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol. Endocrinol. 12:1567-81
127. Zhang J, Zamir I, Lazar MA. 1997. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression. Mol. Cell Biol. 17:6887-97
128. Yoh SM, Privalsky ML. 2001. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor. J. Biol. Chem. 276:16857-67
129. Hu X, Lazar MA. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96
130. Hu X, Li Y, Lazar MA. 2001. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol. Cell Biol. 21:1747-58
131. Marimuthu A, Feng W, Tagami T, Nguyen H, Jameson JL, et al. 2002. TR surfaces and conformations required to bind nuclear receptor corepressor. Mol. Endocrinol. 16:271-86
132. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, et al. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:3198-208
133. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O'Malley BW. 1995. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell Biol. 15:76-86
134. Baniahmad A, Thormeyer D, Renkawitz R. 1997. tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau 4 activation function and full dissociation of corepressors. Mol. Cell Biol. 17:4259-71
135. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au-Fliegner M, et al. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell Biol. 14:5756-65
136. Lin BC, Hong SH, Krig S, Yoh SM, Privalsky ML. 1997. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol. Cell Biol. 17:6131-38
137. Nagy L, Kao HY, Love JD, Li C, Banayo E, et al. 1999. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:3209-16
138. Sachs LM, Jones PL, Havis E, Rouse N, Demeneix BA, Shi YB. 2002. Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis development. Mol. Cell Biol. 22:8527-38
139. Zhang J, Hu X, Lazar MA. 1999. A novel role for helix 12 of retinoid X receptor in regulating repression. Mol. Cell Biol. 19:6448-57
140. Bailey PJ, Dowhan DH, Franke K, Burke LJ, Downes M, Muscat GE. 1997. Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13delta1. J. Steroid Biochem. Mol. Biol. 63:165-74
141. Shibata H, Nawaz Z, Tsai SY, O'Malley BW, Tsai MJ. 1997. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11:714-24
142. Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M. 1999. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J. Biol. Chem. 274:15901-7
143. Dwivedi PP, Muscat GE, Bailey PJ, Omdahl JL, May BK. 1998. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. J. Mol. Endocrinol. 20:327-35
144. Herdick M, Carlberg C. 2000. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. J. Mol. Biol. 304:793-801
145. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, et al. 2002. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J. Biol. Chem. 277:19649-57
146. Ruse MD Jr, Privalsky ML, Sladek FM. 2002. Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain. Mol. Cell Biol. 22:626-38
147. Shi Y, Hon M, Evans RM. 2002. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl. Acad. Sci. USA 99:2613-18
148. Sohn YC, Kwak E, Na Y, Lee JW, Lee SK. 2001. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J. Biol. Chem 276:43734-39
149. Tagami T, Lutz WH, Kumar R, Jameson JL. 1998.The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun. 253:358-63
150. Torres-Padilla ME, Sladek FM, Weiss MC. 2002. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J. Biol. Chem. 277:4677-87
151. Dotzlaw H, Moehren U, Mink S, Cato AC, Iniguez Lluhi JA, Baniahmad A. 2002. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol. Endocrinol. 16:661-73
152. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:693-705
153. Liu Z, Auboeuf D, Wong J, Chen JD, Tsai SY, et al. 2002. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc. Natl. Acad. Sci. USA 99:7940-44
154. Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R. 2002. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 277:26238-43
155. Shang Y, Brown M. 2002. Molecular determinants for the tissue specificity of SERMs. Science 295:2465-68
156. Shang Y, Myers M, Brown M. 2002. Formation of the androgen receptor transcription complex. Mol. Cell 9:601-10
157. Smith CL, Nawaz Z, O'Malley BW. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-66
158. Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. 1996. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc. Natl. Acad. Sci. USA 93:12195-99
159. Zhang X, Jeyakumar M, Petukhov S, Bagchi MK. 1998. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12:513-24
160. Jepsen K, Hermanson O, Onami TM, Gleiberman AS, Lunyak V, et al. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753-63
161. Takimoto GS, Graham JD, Jackson TA, Tung L, Powell RL, et al. 1999. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors. J. Steroid Biochem. Mol. Biol. 69:45-50
162. Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP. 1998. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromocyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell Biol. 18:369-78
163. Elholm M, Dam I, Jorgensen C, Krogsdam AM, Holst D, et al. 2001. Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with co-factors. J. Biol. Chem. 276:21410-16
164. Hong SH, Privalsky ML. 1999. Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha. J. Biol. Chem. 274:2885-92
165. Hu X, Li S, Wu J, Xia C, Lala DS. 2003. Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 17:1019-26
166. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:40-54
167. Sucov HM, Evans RM. 1995. Retinoic acid and retinoic acid receptors in development. Mol. Neurobiol. 10:169-84
168. Hauksdottir H, Farboud B, Privalsky ML. 2003. Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand. Mol. Endocrinol. 17:373-85
169. Farboud B, Hauksdottir H, Wu Y, Privalsky ML. 2003. Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression. Mol. Cell Biol. 23: 2844-58
170. Klein ES, Wang JW, Khalifa B, Gavigan SA, Chandraratna RA. 2000. Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions. J. Biol. Chem. 275:19401-8
171. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, et al. 1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395:199-202
172. Germain P, Iyer J, Zechel C, Gronemeyer H. 2002. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415:187-92
173. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, et al. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-31
174. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, et al. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-54
175. Olson DP, Sun B, Koenig RJ. 1998. Thyroid hormone response element
176. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, et al. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9:45-57
177. Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, Shiekhattar R. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14:1048-57
178. Guenther MG, Barak O, Lazar MA. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell Biol. 21:6091-101
179. Guenther MG, Yu J, Kao GD, Yen TJ, Lazar MA. 2002. Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev. 16:3130-35
180. Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19:4342-50
181. Underbill C, Qutob MS, Yee SP, Torchia J. 2000. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275:40463-70
182. Urnov FD, Yee J, Sachs L, Collingwood TN, Bauer A, et al. 2000. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J. 19:4074-90
183. Wen YD, Perissi V, Staszewski LM, Yang WM, Krones A, et al. 2000. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 97:7202-7
184. Zhang J, Kalkum M, Chait BT, Roeder RG. 2002. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9:611-23
185. Fischle W, Dequiedt F, Fillion M, Hendzel MJ, Voelter W, Verdin E. 2001. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J. Biol. Chem. 276:35826-35
186. Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, Lazar MA. 2000. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev. 14:45-54
187. Kao HY, Downes M, Ordentlich P, Evans RM. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:55-66
188. Wu X, Li H, Park EJ, Chen JD. 2001. SMRTE inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains. J. Biol. Chem. 276:24177-85
189. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, et al. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-46
190. Alland L, Muhle R, Hou H Jr, Potes J, Chin L, et al. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55
191. Heinzel T, Lavinsky RM, Mullen TM, Söderstrom M, Laherty CD, et al. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
192. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, et al. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-80
193. Alland L, David G, Shen-Li H, Potes J, Muhle R, et al. 2002. Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol. Cell Biol. 22:2743-50
194. Ayer DE. 1999. Histone deacetylases: transcriptional repression wilh SINers and NuRDs. Trends Cell Biol. 9:193-98
195. Boehmelt G, Antonio L, Iscove NN. 1998. Cloning of the murine transcriptional corepressor component SAP18 and differential expression of its mRNA in the hematopoietic hierarchy. Gene 207:267-75
196. Grandori C, Cowley SM, James LP, Eisenman RN. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653-99
197. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-56
198. Li J, Lin Q, Wang W, Wade P, Wong J. 2002. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. Genes Dev. 16:687-92
199. Rietveld LE, Caldenhoven E, Stunnenberg HG. 2002. In vivo repression of an erythroid-specific gene by distinct corepressor complexes. EMBO J. 21:1389-97
200. Downes M, Ordentlich P, Kao HY, Alvarez JG, Evans RM. 2000. Identification of a nuclear domain with deacetylase activity. Proc. Natl. Acad. Sci. USA 97:10330-35
201. Jones PL, Sachs LM, Rouse N, Wade PA, Shi YB. 2001. Multiple N-CoR complexes contain distinct histone deacetylases. J. Biol. Chem. 276:8807-11
202. Forrest D, Vennstrom B. 2000. Functions of thyroid hormone receptors in mice. Thyroid 10:41-52
203. Wu Y, Koenig RJ. 2000. Gene regulation by thyroid hormone. Trends Endocrinol. Metab. 11:207-11
204. Hollenberg AN, Monden T, Wondisford FE. 1995. Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J. Biol. Chem. 270:14274-80
205. Sjoberg M, Vennstrom B. 1995. Ligand-dependent and -independent transactivation by thyroid hormone receptor beta-2 is determined by the structure of the hormone response element. Mol. Cell Biol. 15:4718-26
206. Hollenberg AN, Monden T, Madura JP, Lee K, Wondisford FE. 1996. Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J. Biol. Chem. 271:28516-20
207. Yang Z, Hong SH, Privalsky ML. 1999. Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J. Biol. Chem. 274:37131-38
208. Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, et al. 1999. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 13:412-23
209. Ueki N, Hayman MJ. 2003. Signaldependent N-CoR requirement for repression by the Ski oncoprotein. J. Biol. Chem. 278:24858-64
210. Shinagawa T, Dong HD, Xu M, Maekawa T, Ishii S. 2000. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice. EMBO J. 19:2280-91
211. Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, et al. 2001. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 15:1140-51
212. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-52
213. Pazin MJ, Kadonaga JT. 1997. What's up and down with histone deacetylation and transcription? Cell 89:325-38
214. Perlmann T, Vennstrom B. 1995. The sound of silence. Nature 377:387-38
215. Workman JL, Kingston RE. 1998. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67:545-79
216. Kuzmichev A, Reinberg D. 2001. Role of histone deacetylase complexes in the regulation of chromatin metabolism. Curr. Top. Microbiol. Immunol. 254:35-58
217. Urnov FD, Wolffe AP, Guschin D. 2001. Molecular mechanisms of corepressor function. Curr. Top. Microbiol. Immunol. 254:1-33
218. Berger SL. 2001. Molecular biology. The histone modification circus. [Comment On: Science. 2001 Apr 6;292(5514):110-3 UI: 21189485]. Science 292:64-65
219. Chen H, Tini M, Evans RM. 2001. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 13:218-24
220. Freiman RN, Tjian R. 2003. Regulating the regulators: lysine modifications make their mark. Cell 112:11-17
221. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-80
222. Richards EJ, Elgin SC. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489-500
223. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403:41-45
224. Agalioti T, Chen G, Thanos D. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381-92
225. Hassan AH, Prochasson P, Neely KE, Galasinski SC, Chandy M, et al. 2002. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111:369-79
226. Mizzen CA, Allis CD. 2000. Transcription. New insights into an old modification. Science 289:2290-91
227. Zeng L, Zhou MM. 2002. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 513:124-28
228. Goll MG, Bestor TH. 2002. Histone modification and replacement in chromatin activation. Genes Dev. 16:1739-42
229. Zegerman P, Canas B, Pappin D, Kouzarides T. 2002. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J. Biol. Chem. 277:11621-24
230. Daujat S, Bauer UM, Shah V, Turner B, Berger S, Kouzarides T. 2002. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr. Biol. 12:2090-97
231. Ma H, Baumann CT, Li H, Strahl BD, Rice R, et al. 2001. Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr. Biol. 11:t1981-85
232. Stallcup MR. 2001. Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene 20:3014-20
233. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, et al. 2001. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:853-57
234. Rice JC, Allis CD. 2001. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13:263-73
235. Ben-Porath I, Cedar H. 2001. Epigenetic crosstalk. Mol. Cell. 8:933-35
236. Bestor TH. 1998. Gene silencing. Methylation meets acetylation. Nature 393:311-12
237. Bird A. 2001. Molecular biology. Methylation talk between histones and DNA. Science 294:2113-15
238. Bird AP, Wolffe AP. 1999. Methylation-induced repression - belts, braces, and chromatin. Cell 99:451-54
239. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, et al. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-89
240. Razin A. 1998. CpG methylation, chromatin structure and gene silencing - a three-way connection. EMBO J. 17:4905-8
241. Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai MJ, O'Malley BW. 1993. Interaction of human thyroid hormone receptor-beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA 90:8832-36
242. Fondell JD, Brunel F, Hisatake K, Roeder RG. 1996. Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression. Mol. Cell Biol. 16:281-87
243. Fondell JD, Roy AL, Roeder RG. 1993. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex - implications for active repression. Genes Dev. 7:1400-10
244. Hadzic E, Desaiyajnik V, Helmer E, Guo S, Wu SJ, et al. 1995. A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol. Cell Biol. 15:4507-17
245. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L. 1994. Human TAF (II)30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-17
246. Hager GL, Fletcher TM, Xiao N, Baumann CT, Muller WG, McNally JG. 2000. Dynamics of gene targeting and chromatin remodelling by nuclear receptors. Biochem. Soc. Trans. 28:405-10
247. McEwan IJ. 2000. Gene regulation through chromatin remodelling by members of the nuclear receptor superfamily. Biochem. Soc. Trans. 28:369-73
248. Feng Q, Zhang Y. 2003. The NuRD complex: linking histone modification to nucleosome remodeling. Curr. Top. Microbiol. Immunol. 274:269-90
249. Knoepfler PS, Eisenman RN. 1999. Sin meets NuRD and other tails of repression. Cell 99:447-50
250. Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H. 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:689-92
251. Sterner DE, Berger SL. 2000. Acetylation of histories and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-59
252. Fu M, Wang C, Wang J, Zhang X, Sakamaki T, et al. 2002. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and transrepression function. Mol. Cell Biol. 22:3373-88
253. Zhou Y, Gross W, Hong SH, Privalsky ML. 2001. The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol. Cell Biochem. 220:1-13
254. Hong SH, Wong CW, Privalsky ML. 1998. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol. Endocrinol. 12:1161-71
255. Hong SH, Privalsky ML. 2000. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell Biol. 20:6612-25
256. Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, et al. 2000. Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res. 60:5887-94
257. Kurokawa H, Arteaga CL. 2001. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Clin. Cancer Res. 7:4436s-42s; discussion 11s-12s
258. Tsuda L, Nagaraj R, Zipursky SL, Banerjee U. 2002. An EGFR/Ebi/Sno pathway promotes delta expression by inactivating Su(H)/SMRTER repression during inductive notch signaling. Cell 110:625-37
259. Hermanson O, Jepsen K, Rosenfeld MG. 2002. N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419:934-39
260. Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, Muscat GE. 2001. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 276:17007-13
261. Grozinger CM, Schreiber SL. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97:7835-40
262. McKinsey TA, Zhang CL, Olson EN. 2001. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol. Cell Biol. 21:6312-21
263. Zhou X, Richon VM, Wang AH, Yang XJ, Rifkind RA, Marks PA. 2000. Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. Proc. Natl. Acad. Sci. USA 97:14329-33
264. Galasinski SC, Resing KA, Goodrich JA, Ahn NG. 2002. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J. Biol. Chem. 277:19618-26
265. Tsai SC, Seto E. 2002. Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem. 277:31826-33
266. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, et al. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3:521-26
267. Juge-Aubry CE, Hammar E, Siegrist-Kaiser C, Pernin A, Takeshita A, et al. 1999. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274:10505-10
268. Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, et al. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184-86
269. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ. 2001. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276:22177-82
270. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, et al. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 8:971-82
271. Ratajczak T. 2001. Protein coregulators that mediate estrogen receptor function. Reprod. Fertil. Dev. 13:221-29
272. Rowan BG, Garrison N, Weigel NL, O'Malley BW 2000. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol. Cell Biol. 20:8720-30
273. Wu RC, Qin J, Hashimoto Y, Wong J, Xu J, et al. 2002. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by IkappaB kinase. Mol. Cell Biol. 22:3549-61
274. Zhang J, Guenther MG, Carthew RW, Lazar MA. 1998. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev. 12:1775-80
275. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H. 2000. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin. Cancer Res. 6:512-18
276. Martinez de Arrieta C, Koibuchi N, Chin WW. 2000. Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status. Endocrinology 141:1693-98
277. Feng X, Jiang Y, Meltzer P, Yen PM. 2001. Transgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferation. J. Biol. Chem. 276:15066-72
278. Koide T, Downes M, Chandraratna RA, Blumberg B, Umesono K. 2001. Active repression of RAR signaling is required for head formation. Genes Dev. 15:2111-21
279. Sachs LM, Amano T, Shi YB. 2001. An essential role of histone deacetylases in postembryonic organ transformations in Xenopus laevis. Int. J. Mol. Med. 8:595-601
280. Berghagen H, Ragnhildstveit E, Krogsrud K, Thuestad G, Apriletti J, Saatcioglu F. 2002. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element. J. Biol. Chem. 277:49517-22
281. Satoh T, Monden T, Ishizuka T, Mitsuhashi T, Yamada M, Mori M. 1999. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene. Mol. Cell Endocrinol 154:137-49
282. Tagami T, Madison LD, Nagaya T, Jameson JL. 1997. Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol. Cell Biol. 17:2642-48
283. Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M. 2003. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol. Endocrinol 17:79-92
284. Becker N, Seugnet I, Guissouma H, Dupre SM, Demeneix BA. 2001. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation. Endocrinology 142:5321-31
285. Li X, Kimbrel EA, Kenan DJ, McDonnell DP. 2002. Direct interactions between corepressors and coactivators permit the integration of nuclear receptormediated repression and activation. Mol. Endocrinol. 16:1482-91
286. Chatterjee VK. 2001. Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance. Biochem. Soc. Trans. 29:227-31
287. Jameson JL. 1994. Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone. Thyroid 4:485-92
288. Clifton-Bligh RJ, de Zegher F, Wagner RL, Collingwood TN, Francois I, et al. 1998. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Mol. Endocrinol. 12:609-21
289. Matsushita A, Misawa H, Andoh S, Natsume H, Nishiyama K, et al. 2000. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. J. Endocrinol. 167:493-503
290. Nagaya T, Fujieda M, Seo H. 1998. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition. Biochem. Biophys. Res. Commun. 247:20-23
291. Safer JD, Cohen RN, Hollenberg AN, Wondisford FE. 1998. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. J. Biol. Chem. 273:30175-82
292. Yoh SM, Chatterjee VK, Privalsky ML. 1997. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11:470-80
293. Yoh SM, Privalsky ML. 2000. Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Mol. Cell Endocrinol. 159:109-24
294. Tagami T, Gu WX, Peairs PT, West BL, Jameson JL. 1998. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol. Endocrinol. 12:1888-902
295. Liu Y, Takeshita A, Misiti S, Chin WW, Yen PM. 1998. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors. Endocrinology 139:4197-204
296. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, et al. 1999. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-83
297. Breems-de Ridder MC, Lowenberg B, Jansen JH. 2000. Retinoic acid receptor fusion proteins: friend or foe. Mol. Cell. Endocrinol. 165:1-6
298. Dong S, Tweardy DJ. 2002. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood 99:2637-46
299. Minucci S, Pelicci PG. 1999. Retinoid receptors in health and disease: coregulators and the chromatin connection. Semin. Cell Dev. Biol. 10:215-25
300. Pandolfi PP. 1996. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. Haematologica 81:472-82
301. Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, et al. 1999. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. Proc. Natl. Acad. Sci. USA 96:6318-23
302. Dong S, Qiu J, Stenoien DL, Brinkley WR, Mancini MA, Tweardy DJ. 2003. Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus. Oncogene 22:858-68
303. Grignani F, DeMatteis S, Nervi C, Tomassoni L, Gelmetti V, et al. 1998. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815-18
304. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A. 1998. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML-and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634-42
305. Lin RJ, Evans RM. 2000. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol. Cell 5:821-30
306. Minucci S, Maccarana M, Cioce M, De LucaP, Gelmetti V, et al. 2000. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol. Cell 5:811-20
307. So CW, Dong S, So CK, Cheng GX, Huang QH, et al. 2000. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional coactivator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia. Leukemia 14:77-83
308. Kogan SC, Hong SH, Shultz DB, Privalsky ML, Bishop JM. 2000. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 95:1541-50
309. Gu BW, Xiong H, Zhou Y, Chen B, Wang L, et al. 2002. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. Proc. Natl. Acad. Sci. USA 99:7640-45
310. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, et al. 2001. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol. Cell 7:1233-43
311. Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Ley TJ. 2000. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc. Natl. Acad. Sci. USA 97:13306-11
312. Hong SH, Yang Z, Privalsky ML. 2001. Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol. Cell Biol 21:7172-82
313. Rietveld LE, Caldenhoven E, Stunnenberg HG. 2001. Avian erythroleukemia: a model for corepressor function in cancer. Oncogene 20:3100-9
314. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, et al. 1986. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635-40
315. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. 1986. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641-46
316. Ciana P, Braliou GG, Demay FG, von Lindern M, Barettino D, et al. 1998. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. EMBO J. 17:7382-94
317. Damm K, Thompson CC, Evans RM. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-97
318. Chen HW, Privalsky ML. 1993. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol. Cell Biol. 13:5970-80
319. Sharif M, Privalsky ML. 1991. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell 66:885-93
320. Desbois C, Pain B, Guilhot C, Benchaibi M, Ffrench M, et al. 1991. v-erbA oncogene abrogates growth inhibition of chicken embryo fibroblasts induced by retinoic acid. Oncogene 6:2129-35
321. Schroeder C, Gibson L, Zenke M, Beug H. 1992. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Oncogene 7:217-27
322. Chakrabarti SR, Nucifora G. 1999. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochem. Biophys. Res. Commun. 264:871-77
323. Dressel U, Thormeyer D, Altincicek B, Paululat A, Eggert M, et al. 1999. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol. 19:3383-94
324. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C. 2000. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 14:1455-63
325. Ikeda Y. 1996. SF-1: a key regulator of development and function in the mammalian reproductive system. Acta Paediatr. Jpn. 38:412-19
326. Parker KL. 1998. The roles of steroidogenic factor 1 in endocrine development and function. Mol. Cell Endocrinol. 140:59-63
327. Altincicek B, Tenbaum SP, Dressel U, Thormeyer D, Renkawitz R, Baniahmad A. 2000. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J. Biol. Chem. 275:7662-67
328. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. 1998. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell Biol. 18:2949-56
329. Mathur M, Tucker PW, Samuels HH. 2001. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol. Cell Biol. 21:2298-311
330. Potter GB, Beaudoin GM 3rd, DeRenzo CL, Zarach JM, Chen SH, Thompson CC. 2001. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev. 15:2687-701
331. Potter GB, Zarach JM, Sisk JM, Thompson CC. 2002. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol. Endocrinol. 16:2547-60
332. Moraitis AN, Giguere V, Thompson CC. 2002. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol. Cell Biol. 22:6831-41
333. Nibu Y, Zhang H, Bajor E, Barolo S, Small S, Levine M. 1998. dCtBP mediates transcriptional repression by Knirps, Kruppel and Snail in the Drosophila embryo. EMBO J. 17:7009-20
334. Chinnadurai G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9:213-24
335. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, et al. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-51
336. Lee CH, Wei LN. 1999. Characterization of receptor-interacting protein 140 in retinoid receptor activities. J. Biol. Chem. 274:31320-26
337. Subramaniam N, Treuter E, Okret S. 1999. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J. Biol. Chem. 274:18121-27
338. Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA. 1998. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12:864-81
339. Vo N, Fjeld C, Goodman RH. 2001. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell Biol. 21:6181-88
340. Wei LN, Hu X, Chandra D, Seto E, Farooqui M. 2000. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275:40782-87
341. Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS. 1999. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. USA 96:6947-52
342. Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS. 2000. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275:35848-56
343. Martini PG, Delage-Mourroux R, Kraichely DM, Katzenellenbogen BS. 2000. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell Biol. 20:6224-32
344. Norris JD, Fan D, Sherk A, McDonnell DP. 2002. A negative coregulator for the human ER. Mol. Endocrinol. 16:459-68
345. Sharma M, Sun Z. 2001. 5′TG3′ interacting factor interacts with Sin3A and represses AR-mediated transcription. Mol. Endocrinol. 15:1918-28
346. Wu L, Wu Y, Gathings B, Wan M, Li X, et al. 2003. Smad4 as a transcription corepressor for estrogen receptor alpha. J. Biol. Chem. 278:15192-200
347. Seol W, Choi HS, Moore DD. 1996. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336-39
348. Johansson L, Bavner A, Thomsen JS, Farnegardh M, Gustafsson JA, Treuter E. 2000. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol. Cell Biol. 20:1124-33
349. Borgius LJ, Steffensen KR, Gustafsson JA, Treuter E. 2002. Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP. J. Biol. Chem. 277:49761-66
350. Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD. 2000. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol. Cell Biol. 20:187-95
351. Lee YK, Moore DD. 2002. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner. J. Biol. Chem. 277:2463-67
352. Seol W, Chung M, Moore DD. 1997. Novel receptor interaction and repression domains in the orphan receptor SHP. Mol. Cell Biol. 17:7126-31
353. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-82